Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,532,569
-
Total 13F shares
-
30,280,441
-
Share change
-
+30,278,631
-
Total reported value
-
$783,422,213
-
Price per share
-
$25.98
-
Number of holders
-
44
-
Value change
-
+$783,375,221
-
Number of buys
-
43
Institutional Holders of MBX Biosciences, Inc. - Common Stock (MBX) as of Q3 2024
As of 30 Sep 2024,
MBX Biosciences, Inc. - Common Stock (MBX) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,280,441 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., ORBIMED ADVISORS LLC, NEA Management Company, LLC, Deep Track Capital, LP, WELLINGTON MANAGEMENT GROUP LLP, NVP Associates, LLC, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, EcoR1 Capital, LLC, and Driehaus Capital Management LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.